Fortrea Holdings (FTRE) Debt to Equity (2023 - 2026)

Fortrea Holdings (FTRE) reported Debt to Equity of $2.0 for Q1 2026, up 41.75% on a YoY basis from $1.41 in Q1 2025, and up 7.22% quarter-over-quarter from $1.87 in Q4 2025.

Fortrea Holdings (FTRE) Debt to Equity (2023 - 2026) Analysis & Trends

Fortrea Holdings has reported Debt to Equity for 4 years, with the latest figure at $2.0 in Q1 2026.

  • For the quarter ending Q1 2026, Debt to Equity rose 41.75% year-over-year to $2.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 (up 41.75% YoY), and the FY2025 full-year result was $1.87, up 126.36% from the prior year.
  • Debt to Equity for Q1 2026 stood at $2.0, up from $1.87 in the prior quarter.
  • The five-year high for Debt to Equity was $2.0 in Q1 2026, with the low at $0.74 in Q3 2024.
  • Historically, Debt to Equity has averaged $1.28 across 4 years, with a median of $0.98 in 2024.
  • Annual changes were most pronounced in 2024 — Debt to Equity retreated 21.43% — and 2025, when it soared 161.08%.
  • Fortrea Holdings' Debt to Equity stood at $0.93 in 2023, then decreased by 11.13% to $0.83 in 2024, then soared by 126.36% to $1.87 in 2025, then climbed by 7.22% to $2.0 in 2026.
  • The last three Debt to Equity figures came in at $2.0 (Q1 2026), $1.87 (Q4 2025), and $1.94 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.32
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Fortrea Holdings 1.43 Bn 1.28 Bn 123.60 Mn 2.00

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00
Dec 31, 2025 1.87
Sep 30, 2025 1.94
Jun 30, 2025 2.00
Mar 31, 2025 1.41
Dec 31, 2024 0.83
Sep 30, 2024 0.74
Jun 30, 2024 0.77
Mar 31, 2024 1.01
Dec 31, 2023 0.93
Sep 30, 2023 0.95
Jun 30, 2023 0.92